Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026)
Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Voyager Therapeutics |
222.52 Mn |
81.04 Mn |
- |
-117,127.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-117,127.00 |
| Dec 31, 2025 |
-169,487.00 |
| Sep 30, 2025 |
-24,941.00 |
| Jun 30, 2025 |
205,818.00 |
| Mar 31, 2025 |
277,884.00 |
| Dec 31, 2024 |
-57,356.00 |
| Sep 30, 2024 |
166,155.00 |
| Jun 30, 2024 |
218,551.00 |
| Mar 31, 2024 |
27,239.00 |
| Dec 31, 2023 |
30,757.00 |
| Sep 30, 2023 |
-63,804.00 |
| Jun 30, 2023 |
-42,202.00 |
| Mar 31, 2023 |
21,388.00 |
| Dec 31, 2022 |
155,540.00 |
| Sep 30, 2022 |
11,697.00 |
| Jun 30, 2022 |
-272,514.00 |
| Mar 31, 2022 |
-273,120.00 |
| Dec 31, 2021 |
114,630.00 |
| Sep 30, 2021 |
-72,504.00 |
| Jun 30, 2021 |
-122,938.00 |
